Relevance of TSH-receptor antibody levels in predicting disease course in Graves’ orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay-Reference-Cited by-同舟云学术

Relevance of TSH-receptor antibody levels in predicting disease course in Graves’ orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay

Published:2013-06-07 Issue:8 Volume:27 Page:964-971
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Jang S Y,Shin D Y,Lee E J,Lee S Y,Yoon J S

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/eye2013120.pdf

Reference35 articles.

1. Bahn RS . Graves' ophthalmopathy. N Engl J Med 2010; 362 (8): 726–738.

2. Bahn RS . Clinical review 157: pathophysiology of Graves' ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab 2003; 88 (5): 1939–1946.

3. Gorman CA, Bahn RS . Pathogenesis of Graves' ophthalmopathy. Dev Ophthalmol 1989; 20: 1–7.

4. Khoo TK, Bahn RS . Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies. Thyroid 2007; 17 (10): 1013–1018.

5. Eckstein AK, Plicht M, Lax H, Neuhauser M, Mann K, Lederbogen S et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 2006; 91 (9): 3464–3470.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors for thyroid-stimulating immunoglobulin normalization in moderate-to-severe Graves’ orbitopathy: a 36-month longitudinal study;BMC Ophthalmology;2024-08-21

2. Preoperative Risk Factors for Proptosis Recurrence After Rehabilitative Orbital Decompression in Graves’ Orbitopathy Patients;American Journal of Ophthalmology;2024-02

3. Exacerbation of Thyroid Eye Disease and Dysthyroid Optic Neuropathy During Pregnancy: A Case Report;Internal Medicine;2024

4. Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves’ orbitopathy;Frontiers in Endocrinology;2023-05-08

5. Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves’ Orbitopathy;Experimental and Clinical Endocrinology & Diabetes;2023-01-27